10 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 11.4% per year over the past 5 years.
Net income has grown slower than revenue (7.4% vs 11.4% per year).
Operating margin has contracted, at 3.3% in the latest year.
Free cash flow has grown 33.3% per year over the past 5 years.
Shareholder returns
Dividends have been paid for 7 consecutive years, consuming 27.0% of earnings.
The dividend has grown 154.8% per year over the past 5 years.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$274.9B
$6.0B
21.8%
3.3%
—
—
$7.7B
2024
$247.1B
$3.4B
26.1%
3.8%
—
—
$7.5B
2023
$195.3B
$5.2B
31.5%
4.4%
—
—
$7.8B
2022
$180.5B
—
30.8%
4.7%
—
—
$5.9B
2021
$174.1B
—
32.5%
4.6%
—
—
$5.1B
2020
$160.4B
—
35.5%
5.1%
—
—
$10.2B
2019
$153.6B
—
36.4%
5.3%
$8.4B
—
$4.6B
2018
$48.6B
—
90.1%
8.6%
$3.2B
$41.0B
$3.9B
2017
$41.8B
—
94.1%
9.4%
$3.6B
—
$3.0B
2016
$39.8B
—
93.8%
7.8%
$3.6B
—
$3.2B
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$68.5B
$1.7B
21.0%
3.4%
—
—
$7.0B
Dec '25
$72.5B
—
20.3%
3.2%
—
—
$7.7B
Sep '25
$69.7B
—
20.4%
3.7%
—
—
$6.0B
Jun '25
$67.2B
—
20.7%
3.4%
—
—
$4.3B
Mar '25
$65.5B
$1.3B
26.1%
3.0%
—
—
$8.3B
Dec '24
$65.6B
—
25.3%
3.3%
—
—
$7.5B
Sep '24
$63.7B
—
25.3%
4.0%
—
—
$5.9B
Jun '24
$60.5B
—
26.5%
4.0%
—
—
$6.8B
Mar '24
$57.3B
—
27.6%
3.9%
—
—
$8.4B
Dec '23
$51.1B
—
31.0%
4.0%
—
—
$7.8B
Sep '23
$49.0B
—
31.4%
4.6%
—
—
$8.5B
Jun '23
$48.6B
—
31.2%
4.6%
—
—
$9.6B
Mar '23
$46.5B
—
32.4%
4.3%
—
—
$7.9B
Dec '22
$45.8B
—
29.9%
3.8%
—
—
$5.9B
Sep '22
$45.3B
—
29.8%
4.7%
—
—
$7.1B
Jun '22
$45.5B
—
31.5%
5.2%
—
—
$4.4B
Mar '22
$44.0B
—
32.3%
5.0%
—
—
$4.4B
Dec '21
$45.7B
—
31.6%
3.4%
—
—
$5.1B
Sep '21
$44.3B
—
32.1%
5.2%
—
—
$3.5B
Jun '21
$43.1B
—
32.8%
5.0%
—
—
$3.8B
Valuation over time
How the market has priced CI against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 15.4× (Jan '24) to 12.5× (Jun '26).
The price-to-sales ratio has fallen from 0.4× (Mar '23) to 0.3× (Jun '26).
The dividend yield has risen from 2.0% (Mar '23) to 2.2% (Jun '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is CI growing its revenue and profit?
Over the past 5 years, Cigna's revenue has grown 11.4% per year, and net income grown 7.4% per year. These are computed facts, not advice.
How much debt does CI have?
As of FY2025, Cigna reported — of total debt against $7.7B of cash.
What is CI's profit margin?
In FY2025, gross margin was 21.8%, operating margin 3.3%, and net margin 2.2%.
What is CI's P/E ratio?
As of Jun '26, Cigna traded at a price-to-earnings ratio of about 12.5× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.